vs

Side-by-side financial comparison of Civeo Corp (CVEO) and INSMED Inc (INSM). Click either name above to swap in a different company.

INSMED Inc is the larger business by last-quarter revenue ($263.8M vs $161.6M, roughly 1.6× Civeo Corp). Civeo Corp runs the higher net margin — -4.0% vs -124.5%, a 120.5% gap on every dollar of revenue. On growth, INSMED Inc posted the faster year-over-year revenue change (152.6% vs 7.1%). Civeo Corp produced more free cash flow last quarter ($14.5M vs $-264.2M). Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs -1.4%).

The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

CVEO vs INSM — Head-to-Head

Bigger by revenue
INSM
INSM
1.6× larger
INSM
$263.8M
$161.6M
CVEO
Growing faster (revenue YoY)
INSM
INSM
+145.6% gap
INSM
152.6%
7.1%
CVEO
Higher net margin
CVEO
CVEO
120.5% more per $
CVEO
-4.0%
-124.5%
INSM
More free cash flow
CVEO
CVEO
$278.6M more FCF
CVEO
$14.5M
$-264.2M
INSM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
-1.4%
CVEO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVEO
CVEO
INSM
INSM
Revenue
$161.6M
$263.8M
Net Profit
$-6.5M
$-328.5M
Gross Margin
22.7%
83.2%
Operating Margin
-0.1%
-121.2%
Net Margin
-4.0%
-124.5%
Revenue YoY
7.1%
152.6%
Net Profit YoY
58.1%
-39.5%
EPS (diluted)
$-0.58
$-1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVEO
CVEO
INSM
INSM
Q4 25
$161.6M
$263.8M
Q3 25
$170.5M
$142.3M
Q2 25
$162.7M
$107.4M
Q1 25
$144.0M
$92.8M
Q4 24
$151.0M
$104.4M
Q3 24
$176.3M
$93.4M
Q2 24
$188.7M
$90.3M
Q1 24
$166.1M
$75.5M
Net Profit
CVEO
CVEO
INSM
INSM
Q4 25
$-6.5M
$-328.5M
Q3 25
$-455.0K
$-370.0M
Q2 25
$-3.3M
$-321.7M
Q1 25
$-9.8M
$-256.6M
Q4 24
$-15.4M
$-235.5M
Q3 24
$-5.1M
$-220.5M
Q2 24
$8.2M
$-300.6M
Q1 24
$-5.1M
$-157.1M
Gross Margin
CVEO
CVEO
INSM
INSM
Q4 25
22.7%
83.2%
Q3 25
25.7%
79.4%
Q2 25
25.3%
73.9%
Q1 25
20.4%
77.1%
Q4 24
18.6%
75.0%
Q3 24
21.4%
77.3%
Q2 24
25.4%
76.8%
Q1 24
21.5%
76.9%
Operating Margin
CVEO
CVEO
INSM
INSM
Q4 25
-0.1%
-121.2%
Q3 25
4.1%
-257.1%
Q2 25
1.7%
-291.3%
Q1 25
-3.8%
-267.3%
Q4 24
-6.7%
-220.6%
Q3 24
0.0%
-228.4%
Q2 24
6.9%
-319.8%
Q1 24
-1.1%
-192.7%
Net Margin
CVEO
CVEO
INSM
INSM
Q4 25
-4.0%
-124.5%
Q3 25
-0.3%
-260.0%
Q2 25
-2.0%
-299.5%
Q1 25
-6.8%
-276.4%
Q4 24
-10.2%
-225.5%
Q3 24
-2.9%
-236.0%
Q2 24
4.4%
-332.8%
Q1 24
-3.1%
-208.1%
EPS (diluted)
CVEO
CVEO
INSM
INSM
Q4 25
$-0.58
$-1.55
Q3 25
$-0.04
$-1.75
Q2 25
$-0.25
$-1.70
Q1 25
$-0.72
$-1.42
Q4 24
$-1.04
$-1.30
Q3 24
$-0.36
$-1.27
Q2 24
$0.56
$-1.94
Q1 24
$-0.35
$-1.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVEO
CVEO
INSM
INSM
Cash + ST InvestmentsLiquidity on hand
$14.4M
$1.4B
Total DebtLower is stronger
$546.8M
Stockholders' EquityBook value
$174.4M
$739.0M
Total Assets
$477.4M
$2.3B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVEO
CVEO
INSM
INSM
Q4 25
$14.4M
$1.4B
Q3 25
$12.0M
$1.7B
Q2 25
$14.6M
$1.9B
Q1 25
$28.4M
$1.2B
Q4 24
$5.2M
$1.4B
Q3 24
$17.9M
$1.5B
Q2 24
$7.4M
$1.2B
Q1 24
$16.8M
$595.7M
Total Debt
CVEO
CVEO
INSM
INSM
Q4 25
$546.8M
Q3 25
$546.8M
Q2 25
$546.8M
Q1 25
$1.1B
Q4 24
$43.3M
$1.1B
Q3 24
$971.8M
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
CVEO
CVEO
INSM
INSM
Q4 25
$174.4M
$739.0M
Q3 25
$182.5M
$945.6M
Q2 25
$209.4M
$1.2B
Q1 25
$220.7M
$99.2M
Q4 24
$236.4M
$285.4M
Q3 24
$282.2M
$483.4M
Q2 24
$297.4M
$38.8M
Q1 24
$297.4M
$-464.8M
Total Assets
CVEO
CVEO
INSM
INSM
Q4 25
$477.4M
$2.3B
Q3 25
$491.1M
$2.4B
Q2 25
$508.8M
$2.5B
Q1 25
$423.8M
$1.8B
Q4 24
$405.1M
$2.0B
Q3 24
$477.6M
$2.1B
Q2 24
$483.2M
$1.8B
Q1 24
$513.1M
$1.2B
Debt / Equity
CVEO
CVEO
INSM
INSM
Q4 25
0.74×
Q3 25
0.58×
Q2 25
0.44×
Q1 25
11.31×
Q4 24
0.18×
3.93×
Q3 24
2.01×
Q2 24
30.66×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVEO
CVEO
INSM
INSM
Operating Cash FlowLast quarter
$19.3M
$-247.6M
Free Cash FlowOCF − Capex
$14.5M
$-264.2M
FCF MarginFCF / Revenue
8.9%
-100.1%
Capex IntensityCapex / Revenue
3.0%
6.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$2.1M
$-967.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVEO
CVEO
INSM
INSM
Q4 25
$19.3M
$-247.6M
Q3 25
$13.8M
$-219.8M
Q2 25
$-2.3M
$-205.6M
Q1 25
$-8.4M
$-262.1M
Q4 24
$9.5M
$-196.0M
Q3 24
$35.7M
$-180.9M
Q2 24
$32.4M
$-123.0M
Q1 24
$6.0M
$-184.0M
Free Cash Flow
CVEO
CVEO
INSM
INSM
Q4 25
$14.5M
$-264.2M
Q3 25
$8.2M
$-222.2M
Q2 25
$-6.8M
$-209.1M
Q1 25
$-13.7M
$-272.2M
Q4 24
$1.8M
$-202.8M
Q3 24
$28.2M
$-184.6M
Q2 24
$27.0M
$-129.7M
Q1 24
$372.0K
$-188.7M
FCF Margin
CVEO
CVEO
INSM
INSM
Q4 25
8.9%
-100.1%
Q3 25
4.8%
-156.1%
Q2 25
-4.2%
-194.6%
Q1 25
-9.5%
-293.2%
Q4 24
1.2%
-194.1%
Q3 24
16.0%
-197.6%
Q2 24
14.3%
-143.6%
Q1 24
0.2%
-250.0%
Capex Intensity
CVEO
CVEO
INSM
INSM
Q4 25
3.0%
6.3%
Q3 25
3.3%
1.7%
Q2 25
2.8%
3.2%
Q1 25
3.7%
10.8%
Q4 24
5.1%
6.5%
Q3 24
4.2%
3.9%
Q2 24
2.8%
7.5%
Q1 24
3.4%
6.2%
Cash Conversion
CVEO
CVEO
INSM
INSM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.93×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons